CEFAZOLIN IN DEXTROSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefazolin In Dextrose, and what generic alternatives are available?
Cefazolin In Dextrose is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in CEFAZOLIN IN DEXTROSE is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin In Dextrose
A generic version of CEFAZOLIN IN DEXTROSE was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFAZOLIN IN DEXTROSE?
- What are the global sales for CEFAZOLIN IN DEXTROSE?
- What is Average Wholesale Price for CEFAZOLIN IN DEXTROSE?
Summary for CEFAZOLIN IN DEXTROSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 159 |
| Drug Prices: | Drug price information for CEFAZOLIN IN DEXTROSE |
| DailyMed Link: | CEFAZOLIN IN DEXTROSE at DailyMed |
Recent Clinical Trials for CEFAZOLIN IN DEXTROSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| St. Louis University | Phase 4 |
| Federico II University | N/A |
| Abdul El-Rabbany | Phase 4 |
Pharmacology for CEFAZOLIN IN DEXTROSE
| Drug Class | Cephalosporin Antibacterial |
US Patents and Regulatory Information for CEFAZOLIN IN DEXTROSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | CEFAZOLIN IN DEXTROSE | cefazolin sodium | SOLUTION;INTRAVENOUS | 207131-002 | Feb 1, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare Corp | CEFAZOLIN IN DEXTROSE | cefazolin sodium | SOLUTION;INTRAVENOUS | 207131-001 | Aug 7, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare Corp | CEFAZOLIN IN DEXTROSE | cefazolin sodium | SOLUTION;INTRAVENOUS | 207131-003 | May 31, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
